What Is Radiation Pneumonitis?

Radiation pneumonitis (RP) is an inflammation of the lungs due to radiation therapy or stereotactic body radiotherapy (SBRT) for cancer. Radiation pneumonitis affects between 15% and 40% of people who undergo radiation therapy for lung cancer. It may also develop in patients who undergo chest radiation for breast cancer, lymphomas, thymic tumors, or esophageal cancer.

Radiation Pneumonitis Symptoms

Radiation pneumonitis symptoms can be very similar to lung cancer symptoms or side effects from other cancer treatments, or they can be mistaken for an infection such as pneumonia. Thus, many people disregard or miss these common signs of RP:

• Dyspnea: Shortness of breath that is more pronounced with physical exercise
• Hypoxemia: Low oxygen levels in your blood, which can cause confusion and increased heart rate
• Low-grade fever: Persistent fever below 100.4 degrees F
• Dry cough: Frequent cough with no phlegm or mucous

Often, the symptoms are mild enough for people to tolerate and recover with no need for additional medical treatment. In other cases, symptoms can be serious and result in severe respiratory problems, including acute respiratory distress syndrome, a potentially life-threatening condition.

This is a good reminder that you should talk to your oncologist about any symptoms related to your breathing or your overall health after lung cancer treatment. Don't assume that a problem is just a side effect that you need to live with. It may be a complication that your healthcare provider can treat.

Cause

While radiation can stop your cancer by killing malignant cells, it can also damage healthy cells. Radiation is thought to cause direct damage to the cells of the alveoli, (the lung's air sacs) and small blood vessels. Scarring that develops due to this damage may further limit lung function.

Several factors can put you at risk for complications:

• Chemoradiation: Receiving chemotherapy concurrently (at the same time) as radiation therapy raises the likelihood that you'll develop radiation pneumonitis.
• Gender: Although women tend to have less lung tissue than men, the relationship between gender and the development of radiation pneumonitis is unclear.
• Age: Lung cancer patients over age 65 are more susceptible to radiation pneumonitis.
• Tumor location: Several studies have shown that RP is more common when radiation is used on lower lung lobes versus higher lobes.
• Lung function: People who have other lung diseases, such as COPD, are at an increased risk.
• Type of chemotherapy drugs (if applicable): Paraplatin (carboplatin) and Taxol (paclitaxel) are more likely to lead to this specific pulmonary complication.

Smoking and Reduced RP Risk

While smoking is a clear risk of developing lung cancer, it seems to actually offer some protection against developing radiation pneumonitis. That is, those who continue to smoke after radiation are less likely to report symptoms.

It's unclear if the reason could be that people who tend to already have pulmonary symptoms before radiation are less likely to recognize and report symptoms.

Regardless, continuing to smoke during and/or after lung cancer treatment is not advised due to the numerous health risks it imposes, including shorter survival.

Diagnosis

There is no specific diagnostic test to confirm radiation pneumonitis. Instead, your healthcare provider will make a clinical diagnosis based on symptoms.

The analysis might include the following:

• Blood tests that look for signs of infection or inflammation in the blood, such as an increased white blood cell count
• Pulmonary function tests (PFTs) to assess reduced lung volumes or stiffness of the lungs
• Swab test of the throat to look for infection
• Sputum (mucous) culture to check for bacteria
• Chest X-ray that may reveal changes to the parts of the lung that were exposed to radiation
• Computed tomography (CT) scan, which may offer a clearer picture of lung tissue that had been subjected to radiation therapy

Differential Diagnoses

Because RP's symptoms are so similar to those of other lung conditions, your healthcare provider will use the results of tests and an examination to rule out other possible causes, including:

• Pneumonia
• Pulmonary emboli, blood clots that usually start in the legs, break off, and travel to the lungs
• Spread of cancer to other parts of the lung or the other lung

Treatment

Radiation pneumonitis treatment is aimed at decreasing inflammation. Corticosteroids, such as prednisone, are the main course of treatment.

Researchers have also been looking at ways to use targeted therapies to treat the problem. However, studies have yet to find a proven effective treatment.

Prognosis

While radiation pneumonitis can sometimes lead to serious respiratory distress, in the vast majority of cases, it is not a deadly condition. The risk of dying from RP is less than 2%.

Thus, with proper treatment, you should be able to overcome radiation pneumonitis. However, if it goes untreated, RP can lead to pulmonary fibrosis, scarring of the lungs. This condition, which can make breathing very difficult, is one of the known side effects of radiation therapy.

Prevention

Researchers are looking for ways to reduce the risk of radiation pneumonitis among people going through radiation for lung cancer. Multiple strategies are being explored to reduce the risk of radiation pneumonitis, including various drugs like amifostine, pentoxifylline, and ACE inhibitors, but none have entered widespread use.

Soy derivatives have shown promise in mouse studies in reducing lung inflammation and scarring after radiation, but it is not clear whether this effect would be helpful for preventing the condition in humans.

A Word From Verywell

Radiation pneumonitis is very common in people who are treated for cancers such as lung cancer and breast cancer. Thankfully, with treatment, the condition often resolves without going on to cause life-threatening problems. The most important thing you can do is be aware of the possible symptoms and talk to your healthcare provider if you experience any of them.